ACADIA Pharmaceuticals Inc. logo ACAD - ACADIA Pharmaceuticals Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 26
HOLD 10
SELL 1
STRONG
SELL
0
| PRICE TARGET: $34.78 DETAILS
HIGH: $40.00
LOW: $29.00
MEDIAN: $35.00
CONSENSUS: $34.78
UPSIDE: 63.59%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000
Revenue
Revenue 1,071.5 957.8 726.4 517.2 484.1 441.8 339.1 223.8 124.9 17.3 0.1 0.1 1.1 4.9 2.1 42.1 6.4 1.6 7.6 8.1 11.0 4.6 7.4 6.3 3.7 4.3
Cost of Revenue 89.0 81.8 45.7 10.2 19.1 20.6 19.6 18.3 13.1 4.4 76.4 60.6 26.7 18.8 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 982.5 876.0 680.7 507.1 465.0 421.2 319.5 205.5 111.8 12.9 (76.3) (60.5) (25.6) (13.9) 2.1 42.1 6.4 1.6 7.6 8.1 11.0 4.6 7.4 6.3 3.7 4.3
Operating Expenses
R&D Expenses 328.8 303.2 351.6 361.6 239.4 319.1 240.4 187.2 149.2 99.3 73.9 60.6 26.7 18.8 17.3 20.6 41.6 56.8 57.9 49.4 30.8 23.5 16.9 14.9 13.1 9.7
SG&A Expenses 548.9 488.4 402.5 369.1 396.0 388.7 325.6 265.8 255.1 186.5 90.8 32.7 12.7 7.0 7.6 6.5 10.3 11.8 12.3 11.3 15.9 7.2 4.2 4.0 3.8 3.0
Other Expenses 0 (146.5) 0 0 0 0 0 (1.8) 4.0 1.3 2.5 0 0 0 0 0 0 0 0 (3.6) 0 0 0 0 2.1 2.9
Operating Expenses 877.7 645.2 754.1 730.7 635.4 707.8 566.0 452.9 404.3 285.7 164.7 93.3 39.4 25.8 24.9 27.0 51.9 68.6 70.2 57.2 46.8 30.7 21.1 18.9 19.0 15.6
Operating Income
Operating Income 104.8 230.8 (73.4) (223.6) (170.4) (286.6) (246.5) (247.4) (292.4) (272.8) (164.6) (93.2) (38.3) (20.9) (22.9) 15.1 (45.5) (67.0) (62.7) (49.1) (35.8) (26.1) (13.7) (12.6) (15.3) (11.3)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.1 0.2 0 0 0 0 0 0 0 0
Interest Income 31.7 25.5 17.2 6.6 0.6 6.6 11.2 5.3 4.1 2.8 0.5 0.8 0.3 0.0 0.1 0.1 0.4 2.9 0 0 0 0 0 0 0 0
Profitability
EBITDA 138.9 100.2 (67.8) (221.6) (167.1) (283.7) (243.8) (244.4) (289.7) (271.0) (163.5) (93.0) (38.2) (20.8) (22.5) 15.7 (44.4) (67.0) (62.7) (49.1) (32.9) (24.2) (12.4) (11.2) (15.3) (11.3)
EBIT 138.9 84.3 (73.4) (223.6) (170.4) (286.6) (246.5) (247.4) (292.4) (272.8) (164.6) (93.2) (38.3) (20.9) (22.9) 15.1 (45.5) (67.0) (62.7) (49.1) (35.8) (26.1) (13.7) (12.6) (15.3) (11.3)
Income Before Tax 138.9 258.1 (51.0) (213.4) (167.5) (281.0) (234.4) (243.9) (288.3) (270.1) (164.1) (92.5) (37.9) (20.8) (22.8) 15.1 (45.1) (64.2) (56.4) (45.0) (34.1) (25.9) 0 0 0 0
Income Tax Expense (252.1) 31.6 10.2 2.5 0.4 0.6 0.9 1.3 1.1 1.3 0.3 (0.2) 0 (0.1) 0 0 0 0 0 (3.9) (0.0) (0.0) 0.4 0.2 14.4 10.2
Net Income 391 226.5 (61.3) (216.0) (167.9) (281.6) (235.3) (245.2) (289.4) (271.4) (164.4) (92.5) (37.9) (20.8) (22.8) 15.1 (45.1) (64.2) (56.4) (45.0) (34.1) (25.9) (14.1) (12.9) (14.4) (10.2)
Per Share Data
EPS (Basic) 2.32 1.37 -0.37 -1.34 -1.05 -1.79 -1.60 -1.94 -2.36 -2.34 -1.63 -0.95 -0.44 -0.38 -0.44 0.39 -1.20 -1.73 -1.60 -1.61 -1.55 -2.50 -9.66 -8.86 -11.93 -9.53
EPS (Diluted) 2.29 1.36 -0.37 -1.34 -1.05 -1.79 -1.60 -1.94 -2.36 -2.34 -1.63 -0.95 -0.44 -0.38 -0.44 0.39 -1.20 -1.73 -1.60 -1.61 -1.55 -2.50 -1.24 -8.86 -11.93 -9.53
Shares Outstanding 169.3 165.7 163.8 161.7 160.5 157.3 147.2 126.6 122.6 115.9 100.6 97.2 85.7 54.9 52.2 38.6 37.5 37.1 35.2 27.9 22.0 10.4 1.5 1.5 1.2 1.1
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008 2004 2003 2002 2001 2000
Current Assets
Cash & Cash Equivalents 177.7 319.6 188.7 114.8 147.4 326.0 189.7 134.8 69.4 163.6 18.1 21.2 8.3 6.3 4.5 0 0
Short-Term Investments 642.0 436.4 250.2 302.0 373.3 305.9 507.7 338.8 271.9 365.4 28.9 38.9 27.6 20.9 8.0 0 0
Net Receivables 148.2 104.7 102.3 63.1 65.3 50.3 37.9 27.8 18.4 7.1 0 0 0 0 0 0 0
Inventory 34.7 21.9 35.8 6.6 7.9 9.7 6.3 4.1 5.2 4.2 0 0 0 0 0 0 0
Other Current Assets 0 0 0 0 0 0 0 0 0 0 0 0 1.9 0 0 0 0
Total Current Assets 1,062.1 938.3 616.1 507.9 617.8 717.6 760.2 526.1 373.5 547.9 48.5 62.4 37.8 28.3 13.3 0 0
Non-Current Assets
Property, Plant & Equipment 54.9 50.8 56.5 61.6 66.3 56.4 12.7 3.3 2.7 3.1 1.1 2.1 2.5 3.1 2.4 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 108.9 119.8 65.5 0 0 1.1 2.6 4.1 5.5 7.0 0 0 0 0 0 0 0
Long-Term Investments 7.8 0 5.8 13.0 0 7.1 7.1 4.8 2.5 2.4 0 0 0 0 0 0 0
Other Non-Current Assets 80.6 78.9 5.1 5.3 16.0 0.4 0.6 6.7 2.8 3.2 0.1 0.2 0 0.3 0.4 0 0
Total Non-Current Assets 502.1 249.4 132.8 79.9 82.3 65 22.9 14.1 11.0 13.3 1.2 2.3 2.5 3.4 2.8 0 0
Total Assets 1,564.2 1,187.8 749.0 587.8 700.1 782.6 783.2 540.2 384.5 561.2 49.7 64.7 40.4 31.7 16.0 22.0 34.1
Current Liabilities
Account Payables 10.9 16.2 17.5 12.7 6.9 8.5 7.2 3.2 8.8 3.9 2.9 2.3 2.2 1.5 1.1 0 0
Short-Term Debt 11.6 0 9.4 0 0 5.1 3.4 0 0 0 0.4 0.8 1.5 3.2 3.0 0 0
Deferred Revenue 0 0 0 0 0 0 0 0 0 2.6 6.0 0.4 1.3 1.3 0.3 0 0
Other Current Liabilities 254.6 36.6 92.3 49.5 25.9 52.5 31.8 33.5 21.4 21.6 0 0 0.0 0 0 0 0
Total Current Liabilities 277.1 394.9 254.3 125.6 96.1 106.0 74.8 59.6 49.0 42.6 14.7 11.1 8.6 8.2 6.2 0 0
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0 0 0.1 0.4 1.0 1.6 3.5 1.3 5.8
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 19.1 18.1 15.1 9.1 7.0 5.2 2.9 1.6 0.2 0.2 0.2 0.2 0 74.5 46.5 (1.3) (5.8)
Total Non-Current Liabilities 59.7 60.1 62.9 61.8 63.2 49.6 9.2 1.6 0.2 0.2 22.9 0.6 1.0 76.1 50.0 1.3 5.8
Total Liabilities 336.8 455.0 317.2 187.4 159.2 155.6 84.0 61.1 49.2 42.7 37.6 11.7 9.7 84.4 56.1 4.1 56.6
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0
Retained Earnings (1,813.4) (2,204.4) (2,430.8) (2,369.6) (2,153.6) (1,985.7) (1,704.1) (1,468.9) (1,223.7) (934.0) (339.2) (294.1) (94.3) (68.4) (54.3) 0 0
Accumulated Other Comprehensive Income 1.4 0.3 0.0 (1.0) (0.2) 0.0 0.3 (0.4) (0.4) 0.1 0.5 0.3 (1.8) (2.5) (0.9) 0 0
Total Stockholders' Equity 1,227.4 732.8 431.8 400.4 540.9 627.0 699.1 479.1 335.3 518.4 12.1 53.0 30.7 (52.7) (40.1) 17.9 (22.5)
Total Liabilities & Equity 1,564.2 1,187.8 749.0 587.8 700.1 782.6 783.2 540.2 384.5 561.2 49.7 64.7 40.4 31.7 16.0 22.0 34.1
Debt Metrics
Total Debt 52.2 52.0 57.2 62 64.4 49.5 9.8 0 0 0 0.5 1.2 2.5 4.9 6.4 1.3 5.8
Net Debt (125.5) (267.6) (131.5) (52.8) (83.0) (276.5) (179.9) (134.8) (69.4) (163.6) (17.7) (19.9) (5.8) (1.4) 2.0 1.3 5.8
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2005 2004 2003 2002 2000
Operating Activities
Net Income 391 226.5 (61.3) (216.0) (167.9) (281.6) (235.3) (245.2) (289.4) (271.4) (34.1) (25.9) (14.1) (12.9) (10.2)
Depreciation & Amortization 11.8 15.9 5.6 2.0 3.3 2.9 2.8 3.0 2.7 1.8 1.0 1.3 1.3 1.4 0
Stock-Based Compensation 0 67.0 66.4 68.2 63.6 84.4 82.3 81.6 75.5 55.3 1,307.7 2,355.8 0 0 0
Change in Working Capital (89.8) 4.2 18.1 38.0 (24.8) 11.0 3.7 (8.2) (6.4) 4.4 11.4 1.6 1.5 1.1 25.3
Other Non-Cash Items 46.7 (155.8) (12.1) (6.3) 0.1 44.3 (4.6) 1.4 (0.3) 0.1 1.5 2.4 1.4 1.2 (15.1)
Operating Cash Flow 109.8 157.7 16.7 (114.0) (125.7) (136.2) (151.1) (167.5) (217.9) (210.4) (20.3) (20.7) (9.8) (9.2) 0
Investing Activities
Capital Expenditure (4.7) (0.5) (40.0) 0 (1.1) (7.6) (1.1) (2.1) (0.8) (9.5) (1.0) (0.6) (1.8) (0.4) 0
Acquisitions 0 0 (32.0) 0 70.0 (200.1) 164.7 0.0 0 8 0 0 0 0 0
Purchases of Investments (692.6) (505.1) (370.0) (363.2) (492.8) (339.9) (578.6) (331.1) (478.8) (683.4) (54.5) (36.6) (37.1) (12.0) 0
Sales/Maturities of Investments 493.5 328.6 442.0 436.4 422.8 540.0 413.9 261.7 572.1 430.9 48.9 29.9 24.1 16.2 0
Other Investing Activities 0 146.5 32.0 0 (70.0) 200.1 (164.7) 0.0 93.3 (8) 0 0 0 0 0
Investing Cash Flow (302.6) (30.5) 32.0 73.2 (71.1) 192.5 (165.8) (71.5) 92.5 (261.9) (6.7) (7.4) (14.7) 3.8 0
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 (0.8) (1.4) (1.6) 4.4 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0 0 0 0 0 0 0 14.9 (12.5) 0 0 0 0
Financing Cash Flow 49.9 6.8 25.1 8.2 18.2 81.0 371.8 306.6 31.2 533.8 28.4 30.1 26.4 4.4 0
Cash Position
Net Change in Cash (141.9) 133.9 73.8 (32.6) (178.6) 137.3 54.9 67.7 (94.2) 61.5 1.5 2.0 1.9 (1.1) 0
Cash at Beginning 319.6 194.4 114.8 153.2 331.8 194.5 139.6 71.9 163.6 102.1 8.3 6.3 4.5 5.5 0
Cash at End 177.7 328.4 188.7 120.6 153.2 331.8 194.5 139.6 69.4 163.6 9.8 8.3 6.3 4.5 0
Free Cash Flow 105.1 157.2 (23.3) (114.0) (126.8) (143.8) (152.3) (169.6) (218.7) (219.9) (21.3) (21.3) (11.6) (9.6) 0
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000
Income Statement
Revenue 1,071.5 957.8 726.4 517.2 484.1 441.8 339.1 223.8 124.9 17.3 0.1 0.1 1.1 4.9 2.1 42.1 6.4 1.6 7.6 8.1 11.0 4.6 7.4 6.3 3.7 4.3
Gross Profit 982.5 876.0 680.7 507.1 465.0 421.2 319.5 205.5 111.8 12.9 (76.3) (60.5) (25.6) (13.9) 2.1 42.1 6.4 1.6 7.6 8.1 11.0 4.6 7.4 6.3 3.7 4.3
Operating Income 104.8 230.8 (73.4) (223.6) (170.4) (286.6) (246.5) (247.4) (292.4) (272.8) (164.6) (93.2) (38.3) (20.9) (22.9) 15.1 (45.5) (67.0) (62.7) (49.1) (35.8) (26.1) (13.7) (12.6) (15.3) (11.3)
Net Income 391 226.5 (61.3) (216.0) (167.9) (281.6) (235.3) (245.2) (289.4) (271.4) (164.4) (92.5) (37.9) (20.8) (22.8) 15.1 (45.1) (64.2) (56.4) (45.0) (34.1) (25.9) (14.1) (12.9) (14.4) (10.2)
EPS (Diluted) 2.29 1.36 -0.37 -1.34 -1.05 -1.79 -1.60 -1.94 -2.36 -2.34 -1.63 -0.95 -0.44 -0.38 -0.44 0.39 -1.20 -1.73 -1.60 -1.61 -1.55 -2.50 -1.24 -8.86 -11.93 -9.53
Balance Sheet
Cash & Equivalents 177.7 319.6 188.7 114.8 147.4 326.0 189.7 134.8 69.4 163.6 18.1 21.2 8.3 6.3 4.5 0 0
Total Assets 1,564.2 1,187.8 749.0 587.8 700.1 782.6 783.2 540.2 384.5 561.2 49.7 64.7 40.4 31.7 16.0 22.0 34.1
Total Debt 52.2 52.0 57.2 62 64.4 49.5 9.8 0 0 0 0.5 1.2 2.5 4.9 6.4 1.3 5.8
Stockholders' Equity 1,227.4 732.8 431.8 400.4 540.9 627.0 699.1 479.1 335.3 518.4 12.1 53.0 30.7 (52.7) (40.1) 17.9 (22.5)
Cash Flow
Operating Cash Flow 109.8 157.7 16.7 (114.0) (125.7) (136.2) (151.1) (167.5) (217.9) (210.4) (20.3) (20.7) (9.8) (9.2) 0
Capital Expenditure (4.7) (0.5) (40.0) 0 (1.1) (7.6) (1.1) (2.1) (0.8) (9.5) (1.0) (0.6) (1.8) (0.4) 0
Free Cash Flow 105.1 157.2 (23.3) (114.0) (126.8) (143.8) (152.3) (169.6) (218.7) (219.9) (21.3) (21.3) (11.6) (9.6) 0